Stay updated on Pembrolizumab for Rare Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Rare Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Rare Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T19:49:36.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page.
    Difference
    0.0%
    Check dated 2026-02-12T01:53:57.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    New study record dates were added (2026-01-12, 2026-01-29, 2026-01, 2028-12-31). Old dates (2025-07-31, 2025-12-31, 2025-07-29, 2025-07) were removed and the revision tag updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T23:38:02.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Glossary toggle added and a new 'Revision: v3.4.0' label appears alongside 'Last Update Submitted that Met QC Criteria'. The previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.
    Difference
    0.2%
    Check dated 2026-01-28T21:15:46.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page. This appears to be a minor metadata update with no visible content changes.
    Difference
    0.0%
    Check dated 2026-01-14T04:12:48.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a Texas location under Locations and updated the revision to v3.3.3. Removed the HHS Vulnerability Disclosure and the Texas Locations entry from the prior revision (v3.3.2).
    Difference
    0.2%
    Check dated 2025-12-23T21:57:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Rare Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Rare Tumors Clinical Trial page.